×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modérateurs : Pr Jérôme Alexandre & Dr Enora Laas


Cas clinique :  

18:30
Mise en pratique des données de DESKTOP III :

 - Recommandations de surveillance à la fin du traitement initial - Pr Jérôme Alexandre

- Nouvelles stratégies chirurgicales en rechute - Dr Enora Laas
 
19:10
Espérance de vie des patientes sous iPARP : quels nouveaux enjeux en maintenance ?
Dr Manuel Rodrigues
 
19:35
Quelles possibilités de suivi des patientes sous iPARP en pratique courante ?
Mme Pascale Dielenseger
19:45
Discussion Q&A
 

 

Shooting date : 2021-06-22
Last update : 2021-06-29
1 comment
Join the Discussion
  • l D. quand pourra-t-on avoir le replay? Merci

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Saturday, March 22nd 2025 from 09:30am to 12:30pm (GMT+1)
    Honolulu : Friday, March 21st 2025 from 09:30pm to 12:30am (GMT+1)
    San Francisco : Friday, March 21st 2025 from 11:30pm to 02:30am (GMT+1)
    New York : Saturday, March 22nd 2025 from 02:30am to 05:30am (GMT+1)
    Buenos Aires : Saturday, March 22nd 2025 from 04:30am to 07:30am (GMT+1)
    London / Dublin : Saturday, March 22nd 2025 from 07:30am to 10:30am (GMT+1)
    Paris / Berlin : Saturday, March 22nd 2025 from 08:30am to 11:30am (GMT+1)
    Istanbul : Saturday, March 22nd 2025 from 09:30am to 12:30pm (GMT+1)
    Moscou / Dubaï : Saturday, March 22nd 2025 from 11:30am to 02:30pm (GMT+1)
    Bangkok : Saturday, March 22nd 2025 from 02:30pm to 05:30pm (GMT+1)
    Shanghai : Saturday, March 22nd 2025 from 03:30pm to 06:30pm (GMT+1)
    Tokyo : Saturday, March 22nd 2025 from 04:30pm to 07:30pm (GMT+1)
    Sydney : Saturday, March 22nd 2025 from 05:30pm to 08:30pm (GMT+1)
    Wellington : Saturday, March 22nd 2025 from 07:30pm to 10:30pm (GMT+1)

    Transpyrenean Oncogynae Symposium

    Ovarian cancer: from molecular insights to multidisciplinary strategies

    Share
    Tuesday, October 18th 2022 from 06pm to 07:30pm (GMT+2)
    Honolulu : Tuesday, October 18th 2022 from 06am to 07:30am (GMT+2)
    San Francisco : Tuesday, October 18th 2022 from 09am to 10:30am (GMT+2)
    New York : Tuesday, October 18th 2022 from 12pm to 01:30pm (GMT+2)
    Buenos Aires : Tuesday, October 18th 2022 from 01pm to 02:30pm (GMT+2)
    Reykjavik : Tuesday, October 18th 2022 from 04pm to 05:30pm (GMT+2)
    London / Dublin : Tuesday, October 18th 2022 from 05pm to 06:30pm (GMT+2)
    Paris / Berlin : Tuesday, October 18th 2022 from 06pm to 07:30pm (GMT+2)
    Istanbul : Tuesday, October 18th 2022 from 07pm to 08:30pm (GMT+2)
    Moscou / Dubaï : Tuesday, October 18th 2022 from 08pm to 09:30pm (GMT+2)
    Bangkok : Tuesday, October 18th 2022 from 11pm to 12:30am (GMT+2)
    Shanghai : Wednesday, October 19th 2022 from 12am to 01:30am (GMT+2)
    Tokyo : Wednesday, October 19th 2022 from 01am to 02:30am (GMT+2)
    Sydney : Wednesday, October 19th 2022 from 03am to 04:30am (GMT+2)
    Wellington : Wednesday, October 19th 2022 from 05am to 06:30am (GMT+2)

    Evolution de la chirurgie du cancer de l’ovaire en 2022

    Share
    Tuesday, December 13th 2022 from 06pm to 07:30pm (GMT+1)
    Honolulu : Tuesday, December 13th 2022 from 06am to 07:30am (GMT+1)
    San Francisco : Tuesday, December 13th 2022 from 08am to 09:30am (GMT+1)
    New York : Tuesday, December 13th 2022 from 11am to 12:30pm (GMT+1)
    Buenos Aires : Tuesday, December 13th 2022 from 01pm to 02:30pm (GMT+1)
    London / Dublin : Tuesday, December 13th 2022 from 04pm to 05:30pm (GMT+1)
    Paris / Berlin : Tuesday, December 13th 2022 from 05pm to 06:30pm (GMT+1)
    Istanbul : Tuesday, December 13th 2022 from 06pm to 07:30pm (GMT+1)
    Moscou / Dubaï : Tuesday, December 13th 2022 from 08pm to 09:30pm (GMT+1)
    Bangkok : Tuesday, December 13th 2022 from 11pm to 12:30am (GMT+1)
    Shanghai : Wednesday, December 14th 2022 from 12am to 01:30am (GMT+1)
    Tokyo : Wednesday, December 14th 2022 from 01am to 02:30am (GMT+1)
    Sydney : Wednesday, December 14th 2022 from 02am to 03:30am (GMT+1)
    Wellington : Wednesday, December 14th 2022 from 04am to 05:30am (GMT+1)

    Last improvements in advanced ovarian cancer treatment

    Trials that have or will impact practices in the management of patients with advanced ovarian cancer

    Share
    Wednesday, January 31st 2024 from 06pm to 07:30pm (GMT+1)
    Honolulu : Wednesday, January 31st 2024 from 06am to 07:30am (GMT+1)
    San Francisco : Wednesday, January 31st 2024 from 08am to 09:30am (GMT+1)
    New York : Wednesday, January 31st 2024 from 11am to 12:30pm (GMT+1)
    Buenos Aires : Wednesday, January 31st 2024 from 01pm to 02:30pm (GMT+1)
    London / Dublin : Wednesday, January 31st 2024 from 04pm to 05:30pm (GMT+1)
    Paris / Berlin : Wednesday, January 31st 2024 from 05pm to 06:30pm (GMT+1)
    Istanbul : Wednesday, January 31st 2024 from 06pm to 07:30pm (GMT+1)
    Moscou / Dubaï : Wednesday, January 31st 2024 from 08pm to 09:30pm (GMT+1)
    Bangkok : Wednesday, January 31st 2024 from 11pm to 12:30am (GMT+1)
    Shanghai : Thursday, February 1st 2024 from 12am to 01:30am (GMT+1)
    Tokyo : Thursday, February 1st 2024 from 01am to 02:30am (GMT+1)
    Sydney : Thursday, February 1st 2024 from 02am to 03:30am (GMT+1)
    Wellington : Thursday, February 1st 2024 from 04am to 05:30am (GMT+1)

    KELIM ou comment optimiser l’utilisation du CA 125 dans la prise en charge du cancer de l’ovaire...

    Share
    Scroll Up